Adriblastine and hypokalaemia Patient Reports February 10, 2012

Adriblastine Side Effects Report #5293878-3
Adriblastine side effect was reported by a Health Professional from FRANCE on Mar 30, 2007. Female patient, 46 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Adriblastine. After drug was administered, patient experienced the following side effects: blood calcium decreased, dialysis , febrile bone marrow aplasia, hypokalaemia, renal failure, tubulointerstitial nephritis. Adriblastine dosage: unknown. During the same period patient was treated with DETICENE, HOLOXAN. Patient was hospitalized. Patient recovered.

Adriblastine Side Effects Report #4874838-0
Adriblastine side effect was reported by a Physician from FRANCE on Dec 19, 2005. Female patient, 58 years of age, was treated with Adriblastine. After drug was administered, patient experienced the following side effects: hypochloraemia, hypokalaemia, hyponatraemia, renal disorder. Adriblastine dosage: 40 MG (40 MG, QD), INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE. Patient was hospitalized. Patient recovered.